Certara Announces New Chief Human Resources Officer
13 juil. 2021 08h00 HE
|
Certara
PRINCETON, N.J., July 13, 2021 (GLOBE NEWSWIRE) -- Certara®, a global leader in biosimulation, today announced that it has appointed Nicolette D. Sherman to the position of Chief Human Resources...
Certara Announces Update of BaseCase Software, the Company’s Value Communication Platform
08 juil. 2021 08h00 HE
|
Certara
PRINCETON, N.J., July 08, 2021 (GLOBE NEWSWIRE) -- Certara, a global leader in biosimulation, today announced the release of BaseCase software version 2021.06, which updates the value communication...
Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara’s Biosimulation Software for Evaluating Regulatory Submissions
23 juin 2021 19h00 HE
|
Certara
PRINCETON, N.J., June 23, 2021 (GLOBE NEWSWIRE) -- Certara, a global leader in biosimulation, today announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has renewed its...
Certara Appoints Dr. Carol Gallagher as New Independent Board Member
14 juin 2021 08h00 HE
|
Certara
PRINCETON, N.J., June 14, 2021 (GLOBE NEWSWIRE) -- Certara, a global leader in biosimulation, today announced the addition of Carol Gallagher, Pharm.D., to its board of directors. Dr. Gallagher is...
Certara to Participate in the William Blair Growth Stock Conference and Jefferies Virtual Healthcare Conference
20 mai 2021 08h00 HE
|
Certara
PRINCETON, N.J., May 20, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that William Feehery, Chief Executive Officer, and Andrew Schemick,...
Certara Releases New Versions of Its Preeminent Quantitative Systems Pharmacology (QSP) Simulators for Expediting Development of Biologics and Immuno-oncology Therapies
13 mai 2021 08h00 HE
|
Certara
PRINCETON, N.J., May 13, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), the global leader in biosimulation, today announced the launch of new versions of its Immunogenicity (IG) and...
Certara Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Guidance
06 mai 2021 16h15 HE
|
Certara
PRINCETON, N.J., May 06, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the first quarter of fiscal year 2021. ...
Certara Launches Secondary Intelligence™ Software to Predict Risk of Unwanted Side Effects of Drug Candidates Earlier
04 mai 2021 18h15 HE
|
Certara
PRINCETON, N.J., May 04, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), the global leader in biosimulation, today announced the launch of its Secondary Intelligence™ software, the first and...